The "old" and "current" nuclear medicine imaging in locally advanced breast cancer patient evaluation: 99mTc-MIBI mammoscintigraphy (MMS) and fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT)

被引：0
|
作者：
Evangelista, L. [1 ]
Cervino, A. R. [1 ]
Sanco, R. [1 ]
Memo, L. [1 ]
Burei, M. [1 ]
Michieletto, S. [2 ]
Saibene, T. [2 ]
Valpione, S. [3 ]
Bozza, F. [2 ]
Ghiotto, C. [3 ]
机构：
[1] Ist Oncol Veneto, Nucl Med Unit, Padua, Italy
[2] Ist Oncol Veneto, Surg Oncol Unit, Padua, Italy
[3] Ist Oncol Veneto, Oncol Unit 2, Padua, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2012年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP643
引用
收藏
页码：S284 / S284
页数：1
相关论文
共 50 条
  • [1] Fluorodeoxyglucose positron-emission tomography (FDG PET)/computed tomography (CT) in bladder cancer
    Goh, Vicky
    Cook, Gary
    BJU INTERNATIONAL, 2013, 112 (06) : 709 - 709
  • [2] Recurrence detection by Fluorodeoxyglucose (FDG) and Positron Emission Tomography (PET)/Computed Tomography (CT) in risk categories of breast cancer
    Evangelista, L.
    Cervino, A. R.
    Vinante, L.
    Zago, G.
    Ghiotto, C.
    Bozza, F.
    Burei, M.
    Gregianin, M.
    Saladini, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S283 - S283
  • [3] Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer
    Goodfellow, Henry
    Viney, Zaid
    Hughes, Paul
    Rankin, Sheila
    Rottenberg, Giles
    Hughes, Simon
    Evison, Felicity
    Dasgupta, Prokar
    O'Brien, Timothy
    Khan, Muhammad Shamim
    BJU INTERNATIONAL, 2014, 114 (03) : 389 - 395
  • [4] Initial Staging Impact of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Locally Advanced Breast Cancer
    Niikura, Naoki
    Liu, Jun
    Costelloe, Colleen M.
    Palla, Shana L.
    Madewell, John E.
    Hayashi, Naoki
    Yu, Tse-Kuan
    Tokuda, Yutaka
    Theriault, Richard L.
    Hortobagyi, Gabriel N.
    Ueno, Naoto T.
    ONCOLOGIST, 2011, 16 (06): : 772 - 782
  • [5] 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) Imaging in the Staging and Prognosis of Inflammatory Breast Cancer
    Alberini, Jean-Louis
    Lerebours, Florence
    Wartski, Myriam
    Fourme, Emmanuelle
    Le Stanc, Elise
    Gontier, E.
    Madar, O.
    Cherel, P.
    Pecking, A. P.
    CANCER, 2009, 115 (21) : 5038 - 5047
  • [6] An economic evaluation of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence
    Auguste, P.
    Barton, P.
    Hyde, C.
    Roberts, T. E.
    HEALTH TECHNOLOGY ASSESSMENT, 2011, 15 (18) : 1 - +
  • [7] Adrenal Imaging: The Value of Additional Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography(FDG-PET/CT) in Pheochromocytoma
    Lee, Yeong Bok
    Shin, Jin Kyeong
    Kwon, Hee Sun
    Son, Jang Won
    Lee, Seong Su
    Kim, Sung Rae
    Kim, Chung Ho
    Yoo, Soon Jib
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [8] Potential role of positron emission tomography/computed tomography with fluorodeoxyglucose (18F-FDG PET/CT) in the initial staging of breast cancer
    Sanchez, Rocio
    Jimenez, Antonio Daniel Gonzalez
    Luquin, Tariq Aroui
    Arnau, Inmaculada Mendoza
    Herrezuelo, Isabel Perez
    REVISTA DE SENOLOGIA Y PATOLOGIA MAMARIA, 2025, 38 (01):
  • [9] Interest of fluorodeoxyglucose (FDG)-positron emission tomography (PET) in the preoperative evaluation of breast cancer.
    Steiner, A.
    Soler, C.
    Bouteille, C.
    Gremillet, E.
    Geissler, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] AN INVESTIGATION INTO THE CURRENT ROLE OF NUCLEAR MEDICINE SCIENTISTS AND POSITRON EMISSION TOMOGRAPHY (PET) WITH DIAGNOSTIC COMPUTED TOMOGRAPHY (CT)
    Holmes, I.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 31 - 31
12345